Navigation Links
Symposium to explore broadening partnerships to spur medical advances for war injuries
Date:7/27/2010

ROCKVILLE, Md. (July 27, 2010)The USU-HJF Military Medicine Symposium will gather prominent civilian and military researchers and clinicians from across the United States to discuss current research and identify opportunities to collaborate and share information that could speed treatments to wounded warriors. The symposium also will bring together a broad spectrum of participants from military health leadership, federal agencies and private research institutions to philanthropists and charitable foundations, representatives of industry, and policymakers.

Co-hosted by the Uniformed Services University of the Health Sciences (USU) and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), the symposium will be held Sept. 23 at the Omni Shoreham Hotel in Washington, D.C. Organized through HJF's Center for Public-Private Partnerships, the symposium encourages military-civilian collaboration as a means of expanding resources for the military medical system and of spurring advances in medical technology to benefit wounded, ill and injured servicemembers.

The 2010 symposium will be made up of three expert-discussion panels on regenerative medicine, suicide prevention and resilience, and civilian-military collaborations. The final panel will be comprised of a variety of prominent leaders in military medicine.

Regenerative Medicine

Opening speaker Army Colonel Robert Hale, D.D.S., chief of oral and maxillofacial surgery at San Antonio Military Medical Center, will address the potential role regenerative medicine could play in treating wounded warriors with disabling cranial, jaw and facial injuries. Commissioned in the U.S. Army Reserves in 1977, Hale was called to active duty in 2003, serving tours in Afghanistan and Iraq.

Following Hale's presentation, a panel on regenerative medicine will feature experts from the Armed Forces Institute of Regenerative Medicine, USU's Center for Neuroscien
'/>"/>

Contact: JoAnn C. Sperber
jsperber@hjf.org
301-294-1234
Henry M. Jackson Foundation for the Advancement of Military Medicine
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Penn presents inaugural symposium on applied mathematics and computational science
2. AVS 55th International Symposium & Exhibition, Oct. 19-24
3. Counter-terrorism symposium held at NJIT tomorrow
4. The Camille & Henry Dreyfus Foundation to host important symposium on chemistry and the environment
5. CTRC-AACR San Antonio Breast Cancer Symposium
6. Childrens National convenes first childhood obesity symposium
7. Survival in a Changing World: The Journal of Experimental Biology 2009 symposium
8. Symposium at UH will address how to put sustainability into practice
9. AAAS Symposium: Emerging threats to tropical, temperate and ocean ecosystems
10. Public Policy Center hosts flood symposium March 10-12
11. Symposium to look at genetic basis of exercise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... of the "The Global Watermarking and Fingerprinting ... http://photos.prnewswire.com/prnh/20130307/600769 This ... media watermarking and fingerprinting markets. Watermarking aims to ...
(Date:12/19/2014)... 2014   LaunchKey , the first decentralized mobile authentication ... of Things era, today announced the close of $3 ... led by Metamorphic Ventures with participation from ENIAC Ventures, ... others.  LaunchKey has raised $4 million to date, and ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this market is ... Chemical sensors help in recording of patient data for ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... today at its 2005 international symposium on Computational ... Folding Project launched on IBM's World Community Grid ... structures. , "This project showcases the enormous power ... at the Institute for Systems Biology. "Through a ...
... body's infection-fighting cells might also contribute to fatty buildups ... Southwestern Medical Center researchers have found. , The molecule, ... death in macrophages, which circulate in the bloodstream and ... The AIM-protected macrophages go on to encourage buildup of ...
... life detection system developed by Carnegie Mellon University scientists ... according to results being presented at the 36th Lunar ... marks the first time a rover-based automated technology has ... which serves as a test bed for technology that ...
Cached Biology News:Institute for Systems Biology Symposium Addresses Need for Better Computational Tools 2Molecule that usually protects infection-fighting cells may cause plaque deposits inside arteries 2Robot-based system developed at Carnegie Mellon detects life in Chile's Atacama desert 2Robot-based system developed at Carnegie Mellon detects life in Chile's Atacama desert 3Robot-based system developed at Carnegie Mellon detects life in Chile's Atacama desert 4
(Date:1/22/2015)... 22, 2015 zFlo Motion , a ... announce an exciting product from a new partner. STT-Systems ... over the past 15 years, with offerings in the optical-motion ... 3D IMU system (inertial measurement unit), iSen, is opening eyes ...
(Date:1/22/2015)... Selexis SA, a serial innovation company with ... used for drug discovery to commercial manufacturing, announced today ... Next-Generation Sequencing (NGS) data packages. The NGS analysis ... ensuring the integrity of the gene, validation of the ...
(Date:1/22/2015)... DIEGO , Jan. 22, 2015   Cypher ... and Sequenom, Inc. (NASDAQ: SQNM ), ... development agreement for next generation noninvasive prenatal tests ... genome interpretation technology, called Mantis™, to advance analysis ...
(Date:1/22/2015)... PRINCETON, N.J. , Jan. 22, 2015  Derma ... tissue regeneration company focused on advanced wound care, ... from placental tissues, have been added to the ... announcement increases the opportunity for the AMNIOEXCEL® and ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5
... ATLANTA, April 4, 2011 CryoLife, Inc. (NYSE: ... processing company, announced today that it has filed ... (FDA) to begin clinical trials for the purpose of obtaining ... control bleeding during surgical procedures or following traumatic injuries. ...
... ORLEANS, April 4, 2011 Orexigen ® ... additional data that showed that overweight and obese ... SR) maintained normal 24-hour circadian patterns over one ... ambulatory blood pressure monitoring (ABPM) sub-study of the ...
... (NASDAQ: OMER ), a biopharmaceutical company committed ... bleeding and disorders of the central nervous system, today ... executive officer, is scheduled to present at the 10th ... City this week.  The presentation is scheduled for Tuesday, ...
Cached Biology Technology:CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 2CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 3CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 4Orexigen® Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring 2Orexigen® Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring 3Orexigen® Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring 4
Anti-rat Dipeptidyl Peptidase IV (DPP IV), CD26, Clone 5E8, Monoclonal Antibody...
Purified Mouse anti-Hu Actopaxin (pS8) Storage Temperature: Refrigerate(2 to 8C)...
... H3 (Lys 4) Immunogen: ... ...RT[ Ac K]Q... in which [ Ac ... human histone H3 Accession ... Weight: Mr ~17kDa ...
... The FastPlax Antibody is used to detect ... the surface of infected cells as early ... basis of the FastPlax Titer Kit, which ... 25-48 hours. The FastPlax Antibody ...
Biology Products: